Robert Iannone - 17 Nov 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Issuer symbol
JAZZ
Transactions as of
17 Nov 2025
Net transactions value
-$1,204,573
Form type
4
Filing time
19 Nov 2025, 20:31:34 UTC
Previous filing
12 Mar 2025
Next filing
21 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Iannone Robert EVP, Global Head of R&D & CMO 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone 19 Nov 2025 0001737329

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale $1,204,573 -7,159 -9% $168.26 72,628 17 Nov 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.